Editorial
Anti-doping testing: a moving target?
Abstract
On July 2, 2018, the Union Cycliste Internationale (UCI) has confirmed that the four-time Tour de France winner Christopher Froome has been cleared by the allegation of possible doping, notified on a urine sample collected during the Tour of Spain 2017, since the positivity of this specimen was no longer considered an adverse analytical finding (AAF) by the World Anti-Doping Agency (WADA) (1).
